These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8852053)

  • 1. Detection and determination of the major metabolites of [3H]cytosine arabinoside by high-performance liquid chromatography.
    Braess J; Pförtner J; Kaufmann CC; Ramsauer B; Unterhalt M; Hiddemann W; Schleyer E
    J Chromatogr B Biomed Appl; 1996 Feb; 676(1):131-40. PubMed ID: 8852053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of 3H-labelled cytosine arabinoside and eight metabolites in cell extracts by high-performance liquid chromatography and scintillation spectrometry.
    Wang LM; Woodward CN; White JC; Capizzi RL
    J Chromatogr; 1989 Jul; 491(2):331-40. PubMed ID: 2808619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of cytosine arabinoside, its nucleotides and metabolites by ion-pair high-performance liquid chromatography.
    Schilsky RL; Ordway FS
    J Chromatogr; 1985 Jan; 337(1):63-71. PubMed ID: 3980658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides.
    Sinkule JA; Evans WE
    J Chromatogr; 1983 May; 274():87-93. PubMed ID: 6575975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of a rapid and sensitive liquid chromatography-mass spectrometry method for simultaneous analysis of cytarabine, cytarabine monophosphate, cytarabine diphosphate and cytarabine triphosphate in the cytosol and nucleus.
    Huang S; Liu L; Liu X; Song L; Huang C; Miao L
    J Pharm Biomed Anal; 2022 Mar; 211():114582. PubMed ID: 35101802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection.
    Uchiyama M; Takamatsu Y; Ogata K; Matsumoto T; Jimi S; Tamura K; Hara S
    Biomed Chromatogr; 2013 Jul; 27(7):818-20. PubMed ID: 23420764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.
    Yang JL; White JC; Capizzi RL
    Cancer Chemother Pharmacol; 1992; 29(3):236-40. PubMed ID: 1733557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and -resistant leukemic cells.
    Colly LP; Richel DJ; Arentsen-Honders W; Starrenburg IW; Edelbroek PM; Willemze R
    Cancer Chemother Pharmacol; 1990; 27(2):151-6. PubMed ID: 2249332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
    Kucera GL; Capizzi RL
    Cancer Res; 1992 Jul; 52(14):3886-91. PubMed ID: 1377599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
    Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive radioimmunoassay for cytarabine and uracil arabinoside in plasma.
    Sato T; Morozumi M; Kodama K; Kuninaka A; Yoshino H
    Cancer Treat Rep; 1984 Nov; 68(11):1357-66. PubMed ID: 6498853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two simple high-performance liquid chromatographic methods for simultaneous determination of 2'-deoxycytidine 5'-triphosphate and cytosine arabinoside 5'-triphosphate concentrations in biological samples.
    Danks MK
    J Chromatogr; 1982 Dec; 233():141-8. PubMed ID: 7161328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro studies on phosphorylation and dephosphorylation of cytosine arabinoside in human leukemic cells.
    Muus P; Drenthe-Schonk A; Haanen C; Wessels H; Linssen P
    Leuk Res; 1987; 11(4):319-25. PubMed ID: 3470578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid-chromatographic monitoring of cytosine arabinoside and its metabolite, uracil arabinoside, in serum.
    Wermeling JR; Pruemer JM; Hassan FM; Warner A; Pesce AJ
    Clin Chem; 1989 Jun; 35(6):1011-5. PubMed ID: 2731341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced retention of cytosine arabinoside and its metabolites and synergistic cytotoxicity by sequential treatment with dipyridamole in L5178Y leukemia.
    Yang JL; White JC; Capizzi RL
    Cancer Chemother Pharmacol; 1990; 26(2):135-8. PubMed ID: 2347039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemic cells.
    Yamauchi T; Ueda T
    Biochem Pharmacol; 2005 Jun; 69(12):1795-803. PubMed ID: 15935150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular dCTP/ara-CTP ratio and the cytotoxic effect of ara-C.
    Kawasaki H; Kuwabara H; Hori H; Higashigawa M; Ohkubo T; Sakurai M
    Cancer Invest; 1991; 9(4):409-13. PubMed ID: 1884247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
    Gandhi V; Xu YZ; Estey E
    Clin Cancer Res; 1998 Jul; 4(7):1719-26. PubMed ID: 9676847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI; Powell W
    Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of 1-beta-D-arabinofuranosylcytosine incorporation into DNA in vivo.
    Spriggs D; Robbins G; Ohno Y; Kufe D
    Cancer Res; 1987 Dec; 47(24 Pt 1):6532-6. PubMed ID: 3479246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.